Progyny (NASDAQ:PGNY – Get Free Report) updated its FY 2024 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 1.540-1.570 for the period, compared to the consensus estimate of 0.710. The company issued revenue guidance of $1.1 billion-$1.2 billion, compared to the consensus revenue estimate of $1.2 billion. Progyny also updated its Q4 guidance to $0.07-0.10 EPS.
Analysts Set New Price Targets
A number of brokerages have recently weighed in on PGNY. Canaccord Genuity Group reduced their price objective on shares of Progyny from $24.00 to $18.00 and set a “hold” rating for the company in a research note on Friday, September 20th. JMP Securities cut shares of Progyny from an “outperform” rating to a “market perform” rating in a research note on Thursday, September 19th. Truist Financial cut their target price on shares of Progyny from $33.00 to $26.00 and set a “buy” rating for the company in a research note on Thursday, September 19th. Canaccord Genuity Group cut shares of Progyny from a “buy” rating to a “hold” rating and cut their target price for the company from $37.00 to $24.00 in a research note on Wednesday, August 7th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $25.00 target price on shares of Progyny in a research note on Tuesday, October 1st. Seven analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $27.73.
View Our Latest Report on Progyny
Progyny Stock Up 0.7 %
About Progyny
Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.
Featured Articles
- Five stocks we like better than Progyny
- Want to Profit on the Downtrend? Downtrends, Explained.
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- Insider Trading – What You Need to Know
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- How to Use the MarketBeat Excel Dividend Calculator
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.